Company news
Universal Ibogaine Inc news in 2022
Universal Ibogaine Inc's news releases, calls and decks from 2022, newest first.
Universal Ibogaine Issues Common Shares Pursuant to Settlement of Claim
December 9, 2022
Universal Ibogaine Undertaking Offering of Convertible Debt Securities and Common Shares
December 1, 2022
Universal Ibogaine Announces Closing of Private Placement
December 1, 2022
Universal Ibogaine Announces Formation of Advisory Board
November 8, 2022
Universal Ibogaine Announces Results of Annual General Meeting
October 5, 2022
Universal Ibogaine Featured in Psychedelics Tonight Documentary Series
September 26, 2022
Universal Ibogaine Announces Kelburn Reopening Date
September 21, 2022
Universal Ibogaine appoints Nick Karos to the Board of Directors
September 6, 2022
Universal Ibogaine Provides Update on Kelburn Recovery Center
August 19, 2022
Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference
June 24, 2022
UNIVERSAL IBOGAINE Engages Investor Relations Firm Blue Digital Media
June 13, 2022
Universal Ibogaine Advises of Departure of David Danziger from the Board of Directors
June 10, 2022
Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference
May 13, 2022
Universal Ibogaine retains Shayne Nyquvest as Capital Markets Advisor
April 29, 2022
Universal Ibogaine Advises of Departure of Marilyn Loewen Mauritz from the Board of Directors
April 21, 2022
Universal Ibogaine provides update on kelburn recovery center operations
April 7, 2022
Universal Ibogaine Announces Frankfurt Stock Exchange Listing
April 6, 2022
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9: 00 a.m. - 5: 00 p.m. EDT
March 24, 2022
Universal Ibogaine expands research team with Julie Dumouchel, Director of clinical trials
March 23, 2022
Universal Ibogaine Announces Approval for Trading on the OTCQB Venture Market
February 28, 2022
Universal Ibogaine Signs Memorandum of Understanding with the Osoyoos Indian Band
February 10, 2022
Universal Ibogaine commences development plan at Kelburn in preparation for ibogaine treatments and provides update on drug supply
February 2, 2022
Universal Ibogaine enters drug supply agreement
January 26, 2022
Kelburn Mental Health & Addiction Treatment Centre Announces New Ownership, New Leadership and New Modalities
January 19, 2022
Universal Ibogaine announces world-class clinical trial partners in advance of clinical trial application or ibogaine in opioid use disorder
January 14, 2022
Universal Ibogaine Announces Change in Leadership
January 10, 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 27 slides · Nov 1, 2022
- Investor Presentation (September 2022)
Investor deck · 28 slides · Sep 7, 2022
- Investor Presentation (March 2022)
Investor deck · 27 slides · March 2022
- Fact Sheet (February 2022)
Fact sheet · 4 slides · February 2022
- Fact Sheet (February 2022)
Fact sheet · 4 slides · February 2022
- Investor Presentation (January 2022)
Investor deck · 26 slides · January 2022